Vous êtes ici : UVSQ RechercheStructures de recherche8 pôles scientifiques

UMR/INSERM

Neuroimagerie cognitive (équipe NEMO) - UMR U992 (INSERM/UVSQ)

Adresse :
NeuroSpin, centre CEA Saclay, Bat 145
91191 Gif-sur-Yvette
Tél :
01 69 08 30 00
Mail :
bechir.jarraya@cea.fr
Sur Internet :
http://www.paris-neuroscience.fr/fr/bechir-jarraya

Informations générales

Structure(s) de rattachement :

UFR Simone Veil - santé

Rattachement(s) externe(s) : Brain imaging,consciousness,Neurological disability,Neuromodulation,Translational neuroscience

Tutelle : Inserm/CEA

Référence : UMR Inserm U992

Département : Biologie, médecine, santé

Organisation

Composition de l'équipe Directeur de lunité Cognitive Neuroimaging Unit :
M. Stanislas Dehaene
Directeur de l'équipe Neuromodulation :
M. Béchir Jarraya
b.jarraya@hopital-foch.org

Effectif de l’équipe :
- Enseignants-chercheurs (nombre, université, école…) : 1 PU-PH (UVSQ), 1 CCA (Université Paris-Descartes), 1 chercheur associé MCU-PH (UVSQ)
- Personnel technique (nombre, organisme, université, école…) : 1 CDD (CEA) 100% , 1 CDI (CEA) 20%
- Chercheurs non statutaires (post-docs, sabbatique, invités…) :1 postdoc
Autres : 2 Master2

Activités

Thèmes de recherche

The long-term objective of this project is to apply high field MRI eventually combined with other neuroscience approaches, to develop physical (e.g. electric neurostimulation) and/or chemical (e.g. pharmacological delivery) devices of neuromodulation that target neuronal sites and manipulate specific aspects of cognition, motor behavior or consciousness, leading ultimately to the development of treatments for patients with related diseases (e.g. disorders of consciousness, Parkinson's disease...).
Brain imaging is a unique opportunity to monitor brain structure and function in vivo in both humans and animal models.
Using high field MRI, eventually combined with other approaches such as EEG, we aim at dissecting key neuronal mechanisms underlying consciousness and other brain functions involved in neurological disabilities. Imaging will serve as a rationale to develop specific neuromodulation tools of the identified neuronal networks and to understand their mechanisms of action. Neuromodulation tools can be invasive (e.g. deep brain stimulation) or non invasive (e.g. transcranial direct current stimulation).
Ultimately the findings will serve as a rationale for clinical trials.